DiagnoCure announces presentation on Previstage GCC at the 2013 ASCO annual meeting
Welcome and thank you for standing by. At this time, all participants are in a listen-only mode. We'll conduct a question-and-answer session during the conference. Today's conference is being recorded. If you have any objections, you may disconnect at this time.
Welcome to Gen-Probe s Fourth Quarter and Full Year 2010 Earnings Conference Call. At this time, all participants are in a listen-only mode. After today s presentation we ll conduct a question-and-answer session. Today's conference is being recorded. If you have any objections, please disconnect at this time.
Hologic Announces Second Quarter Fiscal 2013 Operating Results
Welcome, and thank you for standing by. At this time, all participants will be in a listen-only mode until the question-and-answer session (Operator Instructions). Today's conference is being recorded. If you have any objection, you may disconnect at this time. And I'd like to turn the call over to ...
I d like to thank all participants for holding. All lines will be on listen-only until the question-and-answer portion of today s conference. I d also like to inform participants today's call is being recorded.
Gen-Probe's Michael Watts sees five potential new product launches as delivering top-line growth next year.
DiagnoCure Directors Re-Elected by Shareholders at Annual and Special Meeting of Shareholders
Gen-Probe's CFO Herm Rosenman says the firm has plenty of catalysts that should drive growth for the next several years.
Good day everyone and welcome to the Hologic to Acquire Gen-Probe Conference Call. Today's conference is being recorded. At this time it is my pleasure to turn the conference over to Deb Gordon, VP of Investor Relations, Hologic. Please go ahead